Fig. 3 | Scientific Reports

Fig. 3

From: Assessment of leachables in hospital pharmacy compounded topotecan conditioned in common off-label syringes for intravitreal use

Fig. 3

The release of oleamide and its degradants as well as silicone-based oligomeric contaminant evolving in terms of estimated concentrations at different time points over a period of 12 months. The compounds (along with the laboratory codes) identified, semiquantified and assessed are: Oleamide (LB1), Tetradecanamide (LB3), Hexamethylcyclotrisiloxane (LB4).

Back to article page